Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — Investor Day (2016)
13 slides from Coloplast A/s Class B's investor day presentation, 2016
Slide 1: Wound Care Update
Wound Care Update Coloplast Capital Markets Day 2016 Nicolai Buhl Andersen, SVP Wound Care
Slide 2: In 2010, we launched a Wound Care strategy to turn the business around
In 2010, we launched a Wound Care strategy to turn the business around … Our old strategy Recap on our WC journey 1 Build sustainable leadership positions in key Phase III Emerging Markets 2 Phase II Drive top-line Pursue pockets of growth in mature markets Build a growth platform 3 Bring more innov
Slide 3: … and we believe that we have succeeded in turning the business around
… and we believe that we have succeeded in turning the business around Global Wound Care From 2010 to 2016 we have… Revenue growth (MAT index vs. LY) • Globally, outgrown the AWC market the last 2 consecutive years • In Europe, taken a business in decline to now outgrowing the market • In Other
Slide 4: It is time to set a new ambition for our business
It is time to set a new ambition for our business Shape the Double Become a truly standard of care our business global player …as scaling the business will be the key driver of improved profitability Page 4
Slide 5: To deliver on our new ambition, we need to execute on 6 themes
To deliver on our new ambition, we need to execute on 6 themes • Together with HCPs create a shared standard of care for wound treatment by Shape the standard of 1 expanding the awareness and understanding of the Triangle of Wound Assessment care framework 2 Build a strong product • Build a focused
Slide 6: Together with HCPs, we have an aspiration of taking a proactive role
1 Shape the standard Together with HCPs, we have an aspiration of taking a proactive role in defining the standard of care … This means we will have a pro-active role when it comes to: … Defining how to treat wounds … Delivering best in class medical education … Delivering new product technologies,
Slide 7: We will invest in innovation and build a strong product portfolio
2 Build a strong product portfolio We will invest in innovation and build a strong product portfolio Complete Silicone portfolio New AWC solutions Stronger Skin Care portfolio Fewer days with wounds Page 7
Slide 8: In the EU, we have a strong momentum which we believe we can accelerate
3 Accelerate in EU In the EU, we have a strong momentum which we believe we can accelerate Today, we have the fundamentals in Europe UK Revenue growth (MAT index vs. LY) Silicone market share development place but we see the opportunity to do more: • Large opportunity to keep growing 2x within AWC a
Slide 9: In the US, we believe we can make a real difference
4 Strengthen position in the US In the US, we believe we can make a real difference The US is the single largest untapped US market characteristics opportunity for us: • Largest wound care market in the world A large opportunity.. ..with an attractive silicone market.. ..against players we know • To
Slide 10: In China, we want to sustain our leading position
5 Secure leading position in China In China, we want to sustain our leading position China remains a critical market: Top players in China China • Market is growing attractively with Revenue development numerous opportunities • Today, we have a significant sales force and a leading position Coloplas
Slide 11: In Emerging Markets, we will selectively invest in next wave markets
6 Selectively invest in EM In Emerging Markets, we will selectively invest in next wave markets The EM region has a lot of Evaluation criteria Next wave markets opportunity: • EM region consists of +50 markets in Macroeconomic various states of maturity environment • We have proven track-record of g
Slide 12: Our track record tells us it can be done …
Our track record tells us it can be done … 2014/15 2020/21 Shape From a follower... …to shaping the standard of care the standard Shape the AWC industry Coloplast market share within AWC 10-15% 7-8% Double our business Double our business Coloplast expected revenue distribution Become a truly EU Out
Slide 13: Our mission, values and vision
Our mission Making life easier for peoplé with intimate healthcare needs Our values Closeness... to better understand. - Passion... to make a difference Respect and responsibility... to 0 guide | US: Our vision Setting the global standard for listening and responding: Coloplast A/S - Ostomy Care / C